Medpace Holdings Inc (MEDP)
373.61
-0.71
(-0.19%)
USD |
NASDAQ |
Apr 19, 10:13
Medpace Holdings Cash from Operations (TTM): 433.37M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 433.37M |
September 30, 2023 | 413.66M |
June 30, 2023 | 407.77M |
March 31, 2023 | 421.87M |
December 31, 2022 | 388.05M |
September 30, 2022 | 322.26M |
June 30, 2022 | 286.12M |
March 31, 2022 | 252.26M |
December 31, 2021 | 263.33M |
September 30, 2021 | 297.93M |
June 30, 2021 | 285.34M |
March 31, 2021 | 266.85M |
December 31, 2020 | 258.68M |
September 30, 2020 | 210.12M |
June 30, 2020 | 214.65M |
March 31, 2020 | 217.01M |
December 31, 2019 | 201.87M |
Date | Value |
---|---|
September 30, 2019 | 184.37M |
June 30, 2019 | 172.58M |
March 31, 2019 | 167.29M |
December 31, 2018 | 156.58M |
September 30, 2018 | 145.79M |
June 30, 2018 | 132.29M |
March 31, 2018 | 121.36M |
December 31, 2017 | 97.38M |
September 30, 2017 | 97.80M |
June 30, 2017 | 100.97M |
March 31, 2017 | 78.43M |
December 31, 2016 | 91.73M |
September 30, 2016 | 91.12M |
June 30, 2016 | 80.09M |
March 31, 2016 | 93.70M |
December 31, 2015 | 85.87M |
September 30, 2015 | 70.62M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
172.58M
Minimum
Jun 2019
433.37M
Maximum
Dec 2023
289.37M
Average
266.85M
Median
Mar 2021
Cash from Operations (TTM) Benchmarks
Charles River Laboratories International Inc | 683.90M |
Avid Bioservices Inc | 1.705M |
Iovance Biotherapeutics Inc | -361.82M |
Renovaro Inc | -11.49M |
Candel Therapeutics Inc | -34.24M |